Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  American Journal of Psychiatry

• Publication date

  2002-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1176/APPI.AJP.159.6.1055PMID 12042200
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study.

  2002cited by this paper
• Using objective physical activity measures with youth: how many days of monitoring are needed?

  2000cited by this paper
• Risperidone-Associated Weight Gain in Children and Adolescents: A Retrospective Chart Review

  2000cited by this paper
• Antipsychotic-induced weight gain: a comprehensive research synthesis.

  1999cited by this paper
• Body weight gain induced by antipsychotic drugs: mechanisms and management

  1999cited by this paper
• Weight Gain in Adolescents Treated with Risperidone and Conventional Antipsychotics Over Six Months

  1998cited by this paper
• Weight gain associated with neuroleptic medication: a review.

  1995cited by this paper
• Psychometric properties of the K-SADS-P in an Israeli adolescent inpatient population.

  1989cited by this paper
• Psychotropic drug induced weight gain: mechanisms and management.

  1988cited by this paper

• Dietary challenges and desired support strategies in patients with severe mental illness: insights from a qualitative focus group study

  2025influential citation
• The impacts of antipsychotic medications on eating-related outcomes: A mixed methods systematic review

  2025cites this paper
• Histaminergic regulation of food intake

  2023cites this paper
• Eating cognitions, emotions and behaviour under treatment with second generation antipsychotics: A systematic review and meta-analysis

  2023influential citation
• Association between Empathy and Clinical Symptoms among Overweight and Non-Overweight Chinese Chronic Schizophrenia Patients

  2023cites this paper
• Operant training for highly palatable food alters translating mRNA in nucleus accumbens D2 neurons and reveals a modulatory role of Neurochondrin.

  2023cites this paper
• Effects of Immersive Virtual Reality Puzzle Solving Video Games on Cognition, Motor Control, and Functional Behavior in People with Schizophrenia Spectrum Disorders

  2023cites this paper
• Operant training for highly palatable food alters translating mRNA in nucleus accumbens D2 neurons and reveals a modulatory role of Neurochondrin

  2023cites this paper
• Does Chronic Risperidone Administration Affect Food Reinforcement in Adulthood in Mice?

  2022cites this paper
• Nuclear receptor 5A2 regulation of Agrp underlies olanzapine-induced hyperphagia

  2022cites this paper
• Effect of Miricorilant, a Selective Glucocorticoid Receptor Modulator, on Olanzapine-Associated Weight Gain in Healthy Subjects

  2021cites this paper
• Effect of Bifidobacterium on olanzapine-induced body weight and appetite changes in patients with psychosis

  2021cites this paper
• Body mass index increase in preschoolers with heterogeneous psychiatric diagnoses treated with risperidone

  2021cites this paper
• Metabolic and behavioral effects of olanzapine and fluoxetine on the model organism Caenorhabditis elegans

  2021cites this paper
• Traitements pharmacologiques chez l’enfant et chez l’adolescent

  2020cites this paper
• Treatment-related weight gain and metabolic complications in children with mental health disorders: Potential role for lifestyle interventions.

  2020cites this paper
• Exploring Patterns of Disturbed Eating in Psychosis: A Scoping Review

  2020influential citation
• Effect of ursolic acid on olanzapine induced weight gain in Sprague Dawley rats

  2020cites this paper
• Antipsychotic olanzapine-induced misfolding of proinsulin in the endoplasmic reticulum accounts for atypical development of diabetes

  2020cites this paper
• Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients

  2020influential citation
• Brown adipose tissue activity is modulated in olanzapine-treated young rats by simvastatin

  2020cites this paper
• Effects of Transcranial Direct Current Stimulation (tDCS) and Approach Bias Modification training (ABM) on food cravings in people taking antipsychotic medication

  2020cites this paper
• Susceptibility of Male Wild Type Strains to Antipsychotic-induced Weight Gain.

  2020cites this paper
• Metabolomic profiles associated with a mouse model of antipsychotic-induced food intake and weight gain

  2020cites this paper
• Effects of Transcranial Direct Current Stimulation (tDCS) and Approach Bias Modification (ABM) training on food cravings in people taking antipsychotic medication

  2020cites this paper
• Gut Microbiota and Antipsychotics Induced Metabolic Alteration

  2019cites this paper
• Antipsychotics Promote Metabolic Disorders Disrupting Cellular Lipid Metabolism and Trafficking.

  2019cites this paper
• Metformin Triggers PYY Secretion in Human Gut Mucosa.

  2019cites this paper
• Dietary intake of people with severe mental illness: systematic review and meta-analysis

  2019cites this paper
• Effects of Transcranial Direct Current Stimulation (tDCS) and Cognitive Training on food cravings in people taking antipsychotic medication

  2019cites this paper
• 'You are what you eat' (not what you said you ate yesterday): Why a one-off 24-hour dietary recall fails capture usual dietary intake in schizophrenia.

  2018cites this paper
• Harms of Antipsychotics in Children and Young Adults: A Systematic Review Update

  2018influential citation
• A Survey Towards Holistic Management of Schizophrenia

  2018cites this paper
• Pathophysiology of drug induced weight and metabolic effects: findings from an RCT in healthy volunteers treated with olanzapine, iloperidone, or placebo

  2018cites this paper
• Macrophage migration inhibitory factor mediates metabolic dysfunction induced by atypical antipsychotic therapy

  2018cites this paper
• Holistic Management of Schizophrenia Symptoms Using Pharmacological and Non-pharmacological Treatment

  2018cites this paper
• Altered reward anticipation: Potential explanation for weight gain in schizophrenia?

  2017cites this paper
• First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update

  2017influential citation
• Oral haloperidol or olanzapine intake produces distinct and region-specific increase in cannabinoid receptor levels that is prevented by high fat diet.

  2017cites this paper
• Diet and cardiometabolic side effects in children treated with second-generation antipsychotics.

  2017cites this paper
• Roman high and low avoidance rats differ in their response to chronic olanzapine treatment at the level of body weight regulation, glucose homeostasis, and cortico-mesolimbic gene expression

  2017cites this paper
• Prevention of the adverse effects of olanzapine on lipid metabolism with the antiepileptic zonisamide

  2017cites this paper
• Etiopatogeneza metaboličkog sindroma u shizofreniji – najnovije spoznaje

  2017cites this paper
• A review of the nutritional challenges experienced by people living with severe mental illness: a role for dietitians in addressing physical health gaps.

  2017cites this paper
• Cardiometabolic management in severe mental illness requiring an atypical antipsychotic.

  2017cites this paper
• Atypical antipsychotics and effects on feeding: from mice to men

  2016cites this paper
• Physical activity preferences of individuals diagnosed with schizophrenia or bipolar disorder

  2016cites this paper
• The impact of antipsychotic drugs on the expression of genes associated with obesity

  2016cites this paper
• A nutrition intervention is effective in improving dietary components linked to cardiometabolic risk in youth with first-episode psychosis

  2016cites this paper
• Antipsychotics inhibit glucose transport: Determination of olanzapine binding site in Staphylococcus epidermidis glucose/H+ symporter

  2015cites this paper
• Risperidone-induced weight gain and reduced locomotor activity in juvenile female rats: The role of histaminergic and NPY pathways.

  2015cites this paper
• Physical activity and sedentary behavior measured objectively and subjectively in overweight and obese adults with schizophrenia or schizoaffective disorders.

  2015cites this paper
• Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management

  2015cites this paper
• Atypical antipsychotics and metabolic syndrome

  2015cites this paper
• Mécanismes des effets diabétogènes des médicaments antipsychotiques

  2015cites this paper
• Physical Activity and Quality of Life of Outpatients with Schizophrenia.

  2015cites this paper
• Understanding antipsychotic-induced weight gain and other metabolic issues

  2015cites this paper
• Salience network and olanzapine in schizophrenia: implications for treatment in anorexia nervosa.

  2015cites this paper
• Place de la chirurgie bariatrique par sleeve gastrectomie chez le patient bipolaire obèse : nouvelles perspectives

  2015cites this paper
• Treating Obesity in a Vulnerable Clientele Living in Foster Families: A Systemic Solution

  2015cites this paper
• Hypothalamic obesity.

  2015cites this paper
• Increased lean body mass as an early indicator of olanzapine-induced weight gain in healthy men

  2015cites this paper
• Mechanisms for the development of olanzapine-induced weight gain: roles of ghrelin signalling, thermogenesis, and inflammation

  2014cites this paper
• Dietary energy intakes in children with mental health conditions treated with second‐generation antipsychotics (371.8)

  2014cites this paper
• Aumento de peso y de índice de masa corporal en niños y adolescentes tratados con antipsicóticos: revisión crítica y estudio longitudinal

  2014influential citation
• Comparison of predictive equations for resting energy expenditure among patients with schizophrenia in Japan

  2014cites this paper
• Effect of Gestational Exposure to Novel Antipsychotics on Body Weight Gain in Rats

  2014cites this paper
• The effects of second-generation antipsychotics on food intake, resting energy expenditure and physical activity

  2014cites this paper
• Prenatal exposure of a novel antipsychotic aripiprazole: impact on maternal, fetal and postnatal body weight modulation in rats.

  2014cites this paper
• Management von Nebenwirkungen für eine positive Langzeitprognose

  2014cites this paper
• Effects of a group physical activity program on physical fitness and quality of life in individuals with schizophrenia

  2014cites this paper
• Molecular pathophysiology of metabolic effects of antipsychotic medications.

  2014cites this paper
• Effect of Gestational Exposure to Novel Antipsychotics on Body Weight Gain in Rats

  2014cites this paper
• Modelling olanzapine-induced weight gain in rats.

  2014cites this paper
• Selection, use and psychometric properties of physical activity measures to assess individuals with severe mental illness: a narrative synthesis.

  2014cites this paper
• Unhealthy lifestyle in early psychoses: the role of life stress and the hypothalamic-pituitary-adrenal axis.

  2014cites this paper
• Examining Cardiorespiratory Fitness in Diabetic Individuals with and without Psychotic Illness

  2014cites this paper
• Differential role of D1 and D2 receptors in the perifornical lateral hypothalamus in controlling ethanol drinking and food intake: possible interaction with local orexin neurons.

  2014cites this paper
• Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis

  2014cites this paper
• Recent evidence and potential mechanisms underlying weight gain and insulin resistance due to atypical antipsychotics.

  2013cites this paper
• Effects of antipsychotic medications on appetite, weight, and insulin resistance.

  2013cites this paper
• The dietary pattern of patients with schizophrenia: a systematic review.

  2013influential citation
• Effects of risperidone on energy balance in female C57BL/6J mice

  2013influential citation
• Effects of olanzapine versus risperidone on body mass index, serum leptin and lipid profile in schizophrenic patients

  2013cites this paper
• Effects of ziprasidone and olanzapine on body composition and metabolic parameters: an open-label comparative pilot study

  2013influential citation
• Risperidone for Night Terrors and Sleepwalking in an Adult: A Case Report

  2013cites this paper
• Formation of polymeric films containing supersaturated levonorgestrel contraceptive drug by transdermal metered dose aerosol

  2013cites this paper
• The role of hypothalamic pathways in the metabolic side effects of Olanzapine

  2013cites this paper
• Sedentary behavior and psychiatric symptoms in overweight and obese adults with schizophrenia and schizoaffective disorders (WAIST Study).

  2013cites this paper
• In Vivo Pharmacological Evaluations of Novel Olanzapine Analogues in Rats: A Potential New Avenue for the Treatment of Schizophrenia

  2013cites this paper
• Influencia de la administración de psicofármacos en el aumento del peso corporal

  2013cites this paper
• Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review

  2013cites this paper
• A randomized, 12-week study of the effects of extended-release paliperidone (paliperidone ER) and olanzapine on metabolic profile, weight, insulin resistance, and β-cell function in schizophrenic patients

  2013cites this paper
• Pathophysiology and clinical characteristics of hypothalamic obesity in children and adolescents

  2013cites this paper
• Síndrome metabólico secundario a antipsicóticos en niños y adolescentes no tratados previamente

  2013cites this paper
• Technical issues concerning peripheral and central administration of Olanzapine in rats

  2013cites this paper
• Interaction between weight and medications in psychological illnesses of children.

  2013cites this paper
• New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of mania

  2013cites this paper
• Olanzapine and sibutramine have opposing effects on the motivation for palatable food

  2012cites this paper
• Are there different neural mechanisms responsible for three stages of weight gain development in anti-psychotic therapy: temporally based hypothesis.

  2012cites this paper